Summary
Microchip Technology Inc. reported financial results for the quarter ended June 30, 2015, showing a slight increase in net sales of 1.0% year-over-year to $534.0 million, primarily driven by the acquisition of ISSC and market share gains, which offset weaker industry conditions. The company's strategic focus remains on the embedded control market, with microcontrollers constituting the largest segment of sales at 65.2%. Gross profit remained relatively stable at 57.9%, with stability attributed to proprietary product lines and cost reduction efforts, though slightly impacted by inventory write-downs and acquisition-related inventory fair value adjustments. Financially, the company maintained a strong liquidity position with $2,430.6 million in cash, cash equivalents, and investments. Net cash provided by operating activities increased to $181.5 million, indicating healthy cash generation. The company also announced a definitive agreement to acquire Micrel for approximately $839 million, a move expected to be financed by debt and stock. Microchip continues to invest in research and development, maintaining its commitment to new product innovation and process technology enhancements to sustain its competitive edge in the dynamic semiconductor market.
Financial Highlights
55 data points| Revenue | $533.95M |
| Cost of Revenue | $224.94M |
| Gross Profit | $309.02M |
| R&D Expenses | $84.68M |
| SG&A Expenses | $66.85M |
| Operating Expenses | $187.70M |
| Operating Income | $121.32M |
| Interest Expense | $24.05M |
| Net Income | $130.67M |
| EPS (Basic) | $0.33 |
| EPS (Diluted) | $0.30 |
| Shares Outstanding (Basic) | 404.46M |
| Shares Outstanding (Diluted) | 433.53M |
Key Highlights
- 1Net sales increased by 1.0% to $534.0 million for the three months ended June 30, 2015, compared to $528.9 million in the prior year period, driven by acquisition of ISSC and market share gains.
- 2Microcontrollers remain the largest product segment, accounting for 65.2% of net sales in the quarter.
- 3Gross profit margin was 57.9%, a slight decrease from 58.0% in the prior year, influenced by inventory write-downs and acquisition-related inventory adjustments.
- 4The company ended the quarter with a strong liquidity position, holding $2,430.6 million in cash, cash equivalents, and investments.
- 5Net cash provided by operating activities increased to $181.5 million for the quarter, up from $165.8 million in the prior year.
- 6A definitive agreement to acquire Micrel for approximately $839 million was announced and expected to close shortly after the reporting period.
- 7The company continues to invest in R&D, with expenses at $84.7 million (15.9% of net sales), reflecting a commitment to new product development.